Novo CEO pressed by Senate to chop prices of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would think about new talks with insurers regarding the record prices of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. https://ayahealthcareaddress86285.canariblogs.com/the-smart-trick-of-healthcare-news-that-nobody-is-discussing-45840930